221 related articles for article (PubMed ID: 14648705)
1. CD137 and CD137 ligand constitutively coexpressed on human T and B leukemia cells signal proliferation and survival.
Palma C; Binaschi M; Bigioni M; Maggi CA; Goso C
Int J Cancer; 2004 Jan; 108(3):390-8. PubMed ID: 14648705
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD137 and CD137 ligand in colorectal cancer patients.
Dimberg J; Hugander A; Wågsäter D
Oncol Rep; 2006 May; 15(5):1197-200. PubMed ID: 16596186
[TBL] [Abstract][Full Text] [Related]
3. Rapid induction of CD95 ligand and CD4+ T cell-mediated apoptosis by CD137 (4-1BB) costimulation.
Ebata T; Mogi S; Hata Y; Fujimoto JI; Yagita H; Okumura K; Azuma M
Eur J Immunol; 2001 May; 31(5):1410-6. PubMed ID: 11465097
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of CD137 and LPS effects on monocyte activation, survival, and proliferation.
Langstein J; Becke FM; Söllner L; Krause G; Brockhoff G; Kreutz M; Andreesen R; Schwarz H
Biochem Biophys Res Commun; 2000 Jun; 273(1):117-22. PubMed ID: 10873573
[TBL] [Abstract][Full Text] [Related]
5. Murine CD8 lymphocyte expansion in vitro by artificial antigen-presenting cells expressing CD137L (4-1BBL) is superior to CD28, and CD137L expressed on neuroblastoma expands CD8 tumour-reactive effector cells in vivo.
Yan X; Johnson BD; Orentas RJ
Immunology; 2004 May; 112(1):105-16. PubMed ID: 15096190
[TBL] [Abstract][Full Text] [Related]
6. Increased soluble 4-1BB ligand (4-1BBL) levels in peripheral blood of patients with multiple sclerosis.
Liu GZ; Gomes AC; Putheti P; Karrenbauer V; Kostulas K; Press R; Hillert J; Hjelmström P; Gao XG
Scand J Immunol; 2006 Oct; 64(4):412-9. PubMed ID: 16970683
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between OX40/4-1 BB (CD134/CD137) costimulatory molecules expression on T lymphocytes and stimulating and blocking autoantibodies to the TSH-receptor in children with Graves' disease].
Bossowski A; Stasiak-Barmuta A; Urban M; Rinderle C
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):133-40. PubMed ID: 16232366
[TBL] [Abstract][Full Text] [Related]
8. Activation of c-jun N-terminal kinase by 4-1BB (CD137), a T cell co-stimulatory molecule.
Kim HH; Kwack K; Lee ZH
Mol Cells; 2000 Jun; 10(3):247-52. PubMed ID: 10901161
[TBL] [Abstract][Full Text] [Related]
9. CD137 ligand signalling induces differentiation of primary acute myeloid leukaemia cells.
Cheng K; Wong SC; Linn YC; Ho LP; Chng WJ; Schwarz H
Br J Haematol; 2014 Apr; 165(1):134-44. PubMed ID: 24428589
[TBL] [Abstract][Full Text] [Related]
10. The Progress of Investigating the CD137-CD137L Axis as a Potential Target for Systemic Lupus Erythematosus.
Mak A; Schwarz H
Cells; 2019 Sep; 8(9):. PubMed ID: 31500130
[TBL] [Abstract][Full Text] [Related]
11. Soluble CD137 (4-1BB) ligand is released following leukocyte activation and is found in sera of patients with hematological malignancies.
Salih HR; Schmetzer HM; Burke C; Starling GC; Dunn R; Pelka-Fleischer R; Nuessler V; Kiener PA
J Immunol; 2001 Oct; 167(7):4059-66. PubMed ID: 11564827
[TBL] [Abstract][Full Text] [Related]
12. Expression of CD137 and its ligand in human neurons, astrocytes, and microglia: modulation by FGF-2.
Reali C; Curto M; Sogos V; Scintu F; Pauly S; Schwarz H; Gremo F
J Neurosci Res; 2003 Oct; 74(1):67-73. PubMed ID: 13130507
[TBL] [Abstract][Full Text] [Related]
13. Role of 4-1BB:4-1BB ligand in cancer immunotherapy.
Cheuk AT; Mufti GJ; Guinn BA
Cancer Gene Ther; 2004 Mar; 11(3):215-26. PubMed ID: 14671675
[TBL] [Abstract][Full Text] [Related]
14. CD137 (ILA/4-1BB), expressed by primary human monocytes, induces monocyte activation and apoptosis of B lymphocytes.
Kienzle G; von Kempis J
Int Immunol; 2000 Jan; 12(1):73-82. PubMed ID: 10607752
[TBL] [Abstract][Full Text] [Related]
15. CD137 (ILA/4-1BB), a member of the TNF receptor family, induces monocyte activation via bidirectional signaling.
Langstein J; Michel J; Fritsche J; Kreutz M; Andreesen R; Schwarz H
J Immunol; 1998 Mar; 160(5):2488-94. PubMed ID: 9498794
[TBL] [Abstract][Full Text] [Related]
16. Anti-CD137 monoclonal antibody promotes the direct anti-tumor effect mediated by peripheral blood-derived human dendritic cells in vitro.
Zhang L; Wang Q; Wang X; Ding P; Song J; Ma C; Sun W
Cell Mol Immunol; 2004 Feb; 1(1):71-6. PubMed ID: 16212924
[TBL] [Abstract][Full Text] [Related]
17. Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responses.
Taraban VY; Rowley TF; O'Brien L; Chan HT; Haswell LE; Green MH; Tutt AL; Glennie MJ; Al-Shamkhani A
Eur J Immunol; 2002 Dec; 32(12):3617-27. PubMed ID: 12516549
[TBL] [Abstract][Full Text] [Related]
18. CD137 ligand is expressed in primary and secondary lymphoid follicles and in B-cell lymphomas: diagnostic and therapeutic implications.
Zhao S; Zhang H; Xing Y; Natkunam Y
Am J Surg Pathol; 2013 Feb; 37(2):250-8. PubMed ID: 23095505
[TBL] [Abstract][Full Text] [Related]
19. Role of 4-1BB in immune responses.
Vinay DS; Kwon BS
Semin Immunol; 1998 Dec; 10(6):481-9. PubMed ID: 9826581
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD137 on Hodgkin and Reed-Sternberg cells inhibits T-cell activation by eliminating CD137 ligand expression.
Ho WT; Pang WL; Chong SM; Castella A; Al-Salam S; Tan TE; Moh MC; Koh LK; Gan SU; Cheng CK; Schwarz H
Cancer Res; 2013 Jan; 73(2):652-61. PubMed ID: 23204227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
